Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16478) 16478
Publication (2034) 2034
Book Review (347) 347
Book Chapter (70) 70
Book / eBook (28) 28
Conference Proceeding (28) 28
Dissertation (7) 7
Paper (6) 6
Magazine Article (4) 4
Reference (4) 4
Newsletter (3) 3
Newspaper Article (3) 3
Data Set (1) 1
Government Document (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10245) 10245
humans (9016) 9016
animals (7743) 7743
mice (3875) 3875
male (3464) 3464
pharmacology & pharmacy (2944) 2944
female (2870) 2870
proteins (1994) 1994
inflammation (1983) 1983
biochemistry & molecular biology (1977) 1977
analysis (1754) 1754
immunology (1752) 1752
health aspects (1668) 1668
rats (1621) 1621
expression (1610) 1610
cancer (1607) 1607
necrosis-factor-alpha (1595) 1595
article (1568) 1568
cell biology (1567) 1567
research (1530) 1530
in-vitro (1299) 1299
cytokines (1276) 1276
medicine (1268) 1268
gene expression (1262) 1262
apoptosis (1252) 1252
nanoparticles (1246) 1246
medicine, research & experimental (1236) 1236
cell line, tumor (1166) 1166
oncology (1163) 1163
oxidative stress (1152) 1152
research article (1152) 1152
tnf-alpha (1114) 1114
middle aged (1109) 1109
in-vivo (1100) 1100
tumor necrosis factor-alpha - metabolism (1069) 1069
disease models, animal (1064) 1064
cells (1059) 1059
multidisciplinary sciences (1043) 1043
cells, cultured (1039) 1039
adult (1019) 1019
physiological aspects (1018) 1018
cell line (1008) 1008
care and treatment (998) 998
mice, inbred c57bl (989) 989
activation (961) 961
neurosciences (889) 889
therapy (853) 853
rodents (842) 842
biotechnology & applied microbiology (810) 810
science (806) 806
biology (789) 789
signal transduction (782) 782
chemistry, multidisciplinary (779) 779
alpha (777) 777
macrophages (772) 772
toxicology (764) 764
nf-kappa-b (756) 756
tumors (715) 715
review (707) 707
drug delivery systems (701) 701
aged (689) 689
mice, inbred balb c (673) 673
tumor-necrosis-factor (666) 666
genetic aspects (651) 651
inhibition (638) 638
peptides (636) 636
rats, sprague-dawley (631) 631
disease (623) 623
risk factors (622) 622
lipids (619) 619
dendritic cells (614) 614
enzymes (612) 612
gene-expression (605) 605
interferon (597) 597
protein (597) 597
biophysics (592) 592
kinases (587) 587
studies (585) 585
chemistry, medicinal (584) 584
treatment outcome (582) 582
virology (581) 581
liver (578) 578
metabolism (560) 560
time factors (553) 553
alpha-synuclein (549) 549
drugs (543) 543
infection (540) 540
antioxidants (539) 539
medical research (533) 533
genetics & heredity (527) 527
protein binding (524) 524
toxicity (524) 524
particle size (520) 520
gastroenterology & hepatology (519) 519
medicine & public health (516) 516
biomedicine (511) 511
life sciences (511) 511
dose-response relationship, drug (504) 504
biochemistry (501) 501
atherosclerosis (499) 499
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16493) 16493
French (10) 10
Japanese (8) 8
Russian (8) 8
German (7) 7
Chinese (5) 5
Spanish (3) 3
Czech (2) 2
Polish (2) 2
Portuguese (2) 2
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Therapeutic Radiometals Beyond 177 Lu and 90 Y: Production and Application of Promising α-Particle, β - -Particle, and Auger Electron Emitters
by Müller, Cristina and van der Meulen, Nicholas P and Benešová, Martina and Schibli, Roger
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, ISSN 0161-5505, 09/2017, Volume 58, Issue Suppl 2, pp. 91S - 96S
In recent years, new α-particle-, β -particle-, and Auger electron-emitting radiometals-such as Cu, Sc, Ho, Tb, Tb, Pb/ Bi, Ac, and Bi-have been produced and... 
Radiochemistry - methods | Animals | Radioisotopes - therapeutic use | Metals - chemistry | Humans | Beta Particles - therapeutic use | Alpha Particles - therapeutic use | Radioisotopes - chemistry | Electrons
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
by Kratochwil, C and Kratochwil, C and Giesel, F.L and Giesel, F.L and Bruchertseifer, F and Bruchertseifer, F and Mier, W and Mier, W and Apostolidis, C and Apostolidis, C and Boll, R and Boll, R and Murphy, K and Murphy, K and Haberkorn, U and Haberkorn, U and Morgenstern, A and Morgenstern, A
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2014, Volume 41, Issue 11, pp. 2106 - 2119
Radiopeptide therapy using a somatostatin analogue labelled with a beta emitter such as (90)Y/(177)Lu-DOTATOC is a new therapeutic option in neuroendocrine... 
DOTATOC | Targeted alpha therapy (TAT) | 225 Ac | 213 Bi | Humans | Alpha Particles - adverse effects | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Bismuth - therapeutic use | Octreotide - pharmacokinetics | Alpha Particles - therapeutic use | Neoplasm Metastasis | Neuroendocrine Tumors - diagnostic imaging | Treatment Failure | Adult | Female | Receptors, Somatostatin - metabolism | Retrospective Studies | Molecular Targeted Therapy - methods | Neuroendocrine Tumors - pathology | Molecular Targeted Therapy - adverse effects | Radioisotopes - therapeutic use | Octreotide - analogs & derivatives | Octreotide - adverse effects | Octreotide - therapeutic use | Octreotide - pharmacology | Neuroendocrine Tumors - radiotherapy | Beta Particles - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
by Rosenblat, Todd L and McDevitt, Michael R and Mulford, Deborah A and Pandit-Taskar, Neeta and Divgi, Chaitanya R and Panageas, Katherine S and Heaney, Mark L and Chanel, Suzanne and Morgenstern, Alfred and Sgouros, George and Larson, Steven M and Scheinberg, David A and Jurcic, Joseph G
Clinical Cancer Research, ISSN 1078-0432, 11/2010, Volume 16, Issue 21, pp. 5303 - 5311
Purpose: Lintuzumab (HuM195), a humanized anti-CD33 antibody, targets myeloid leukemia cells and has modest single-agent activity against acute myeloid... 
ANTI-CD33 MONOCLONAL-ANTIBODY | RETINOIC ACID | THERAPY | PHARMACOKINETICS | ONCOLOGY | RECOMMENDATIONS | BONE-MARROW-TRANSPLANTATION | INDUCTION | M195 ANTI-CD33 | CHEMOTHERAPY | REMISSION | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Alpha Particles - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Bismuth - therapeutic use | Cytarabine - adverse effects | Alpha Particles - therapeutic use | Bismuth - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Antibodies, Monoclonal, Humanized | Aged, 80 and over | Immunoconjugates - therapeutic use | Leukemia, Myeloid, Acute - drug therapy | Radioimmunotherapy - methods | Adult | Female | Antibodies, Monoclonal - chemistry | Immunoconjugates - adverse effects | Leukemia, Myeloid, Acute - radiotherapy | Radioisotopes - therapeutic use | Drug Administration Schedule | Radioisotopes - adverse effects | Remission Induction | Cytarabine - administration & dosage | Antimetabolites, Antineoplastic - adverse effects | Aged | Radioimmunotherapy - adverse effects | Index Medicus | Alpha-particles | Bismuth-213 | Monoclonal Antibodies | Acute myeloid leukemia | Radioimmunotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antimicrobial and Anti-Inflammatory Activity of Chitosan–Alginate Nanoparticles: A Targeted Therapy for Cutaneous Pathogens
by Friedman, Adam J and Phan, Jenny and Schairer, David O and Champer, Jackson and Qin, Min and Pirouz, Aslan and Blecher-Paz, Karin and Oren, Ami and Liu, Phil T and Modlin, Robert L and Kim, Jenny
Journal of Investigative Dermatology, ISSN 0022-202X, 05/2013, Volume 133, Issue 5, pp. 1231 - 1239
Advances in nanotechnology have demonstrated potential application of nanoparticles (NPs) for effective and targeted drug delivery. Here we investigated the... 
WATER-SOLUBLE CHITOSAN | ANTIBACTERIAL PROPERTIES | MICROSPHERES | ALPHA | ACNE-VULGARIS | RELEASE | MICROPARTICLES | NANOTECHNOLOGY | DELIVERY | DERMATOLOGY | Alginates - therapeutic use | Anti-Infective Agents - pharmacology | Humans | Hexuronic Acids - administration & dosage | Skin Diseases, Bacterial - drug therapy | Drug Delivery Systems | Feasibility Studies | Nanoparticles - therapeutic use | Chitosan - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Chitosan - pharmacology | Anti-Inflammatory Agents - administration & dosage | Glucuronic Acid - administration & dosage | Keratinocytes - microbiology | Alginates - pharmacology | Benzoyl Peroxide - pharmacology | Cell Line | Benzoyl Peroxide - administration & dosage | Benzoyl Peroxide - therapeutic use | Cytokines - metabolism | Anti-Inflammatory Agents - pharmacology | Propionibacterium acnes - physiology | Cells, Cultured | Chitosan - administration & dosage | Acne Vulgaris - drug therapy | Anti-Infective Agents - therapeutic use | Glucuronic Acid - therapeutic use | Alginates - administration & dosage | Glucuronic Acid - pharmacology | Anti-Infective Agents - administration & dosage | Keratinocytes - drug effects | Propionibacterium acnes - ultrastructure | Keratinocytes - metabolism | Nanoparticles - administration & dosage | Propionibacterium acnes - drug effects | Administration, Topical | Hexuronic Acids - pharmacology | Hexuronic Acids - therapeutic use | Index Medicus | Acne | Antimicrobial | Inflammation | Chitosan | Nanoparticle | Skin infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons
by Aghevlian, Sadaf and Boyle, Amanda J and Reilly, Raymond M
Advanced Drug Delivery Reviews, ISSN 0169-409X, 01/2017, Volume 109, pp. 102 - 118
Radioimmunotherapy (RIT) aims to selectively deliver radionuclides emitting α-particles, β-particles or Auger electrons to tumors by conjugation to monoclonal... 
Monoclonal antibodies | Auger electrons | α-Particles | Radiation treatment | Radioimmunotherapy | Cancer | BONE-MARROW-TRANSPLANTATION | RADIOTHERAPEUTIC AGENT IN-111-NLS-TRASTUZUMAB | ACUTE MYELOGENOUS LEUKEMIA | ACUTE MYELOID-LEUKEMIA | GROWING OVARIAN-CANCER | MONOCLONAL-ANTIBODY MOV18 | DISSEMINATED INTRAPERITONEAL DISEASE | EPIDERMAL-GROWTH-FACTOR | alpha-Particles | PHARMACOLOGY & PHARMACY | DISSEMINATED PERITONEAL DISEASE | SITE-SPECIFIC CONJUGATION | Animals | Radioisotopes - therapeutic use | Humans | Radioisotopes - adverse effects | Electrons - therapeutic use | Immunoconjugates - therapeutic use | Neoplasms - radiotherapy | Linear Energy Transfer | Alpha Particles - therapeutic use | Radioimmunotherapy - adverse effects | Immunoconjugates - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles
by Zhu, Jingyi and Zheng, Linfeng and Wen, Shihui and Tang, Yueqin and Shen, Mingwu and Zhang, Guixiang and Shi, Xiangyang
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 26, pp. 7635 - 7646
Abstract Development of multifunctional theranostic nanoplatforms for targeted cancer imaging and therapy still remains a great challenge. Herein, we report... 
Advanced Basic Science | Dentistry | CT imaging | Dendrimers | Alpha-tocopheryl succinate | Targeted cancer therapy | Gold nanoparticles | IRON-OXIDE NANOPARTICLES | MATERIALS SCIENCE, BIOMATERIALS | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | WALLED CARBON NANOTUBES | COMPUTED-TOMOGRAPHY | VITAMIN-E ANALOGS | IN-VIVO | MAGNETIC-RESONANCE | TOMOGRAPHY IMAGING APPLICATIONS | COMPLEX II | POLYETHYLENE-GLYCOL | Nanoparticles - chemistry | Dendrimers - therapeutic use | Humans | Tomography, X-Ray Computed - methods | Vitamin E - analogs & derivatives | Male | Polyethylene Glycols - chemistry | Neoplasms - diagnosis | Polyethylene Glycols - therapeutic use | Neoplasms - therapy | Nanoparticles - therapeutic use | Vitamin E - therapeutic use | Contrast Media - therapeutic use | Vitamin E - chemistry | Gold - chemistry | Folic Acid - chemistry | Nanoparticles - ultrastructure | Animals | Mice, Nude | Cell Line, Tumor | Dendrimers - chemistry | Folic Acid - metabolism | Gold - therapeutic use | Contrast Media - chemistry | Mice, Inbred BALB C | Nanoparticles | Fluorescein | Radiology | Radiology, Medical | Polyols | Folic acid | Cancer | Surgical implants | Therapy | Gold | Biomedical materials | Imaging | Nanostructure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)
by Wild, Damian and Frischknecht, Michael and Zhang, Hanwen and Morgenstern, Alfred and Bruchertseifer, Frank and Boisclair, Julie and Provencher-Bolliger, Anne and Reubi, Jean-Claude and Maecke, Helmut R
Cancer Research, ISSN 0008-5472, 02/2011, Volume 71, Issue 3, pp. 1009 - 1018
Recurrent prostate cancer presents a challenge to conventional treatment, particularly so to address micrometastatic and small-volume disease. Use of... 
NUDE-MICE | MEMBRANE ANTIGEN | PEPTIDES | SOLID TUMORS | GRP | ONCOLOGY | PHASE-I TRIAL | RADIOIMMUNOTHERAPY | RADIOTHERAPY | MONOCLONAL-ANTIBODIES | DELIVERY | Prostatic Neoplasms - radiotherapy | Radiopharmaceuticals - chemistry | Radiopharmaceuticals - pharmacokinetics | Humans | Oligopeptides - pharmacokinetics | Alpha Particles - adverse effects | Male | Radiopharmaceuticals - toxicity | Oligopeptides - toxicity | Alpha Particles - therapeutic use | Oligopeptides - therapeutic use | Bismuth - chemistry | Xenograft Model Antitumor Assays | Animals | Beta Particles - adverse effects | Mice, Nude | Beta Particles - therapeutic use | Female | Lutetium - chemistry | Mice | Oligopeptides - chemistry | Radioisotopes - chemistry | Radiopharmaceuticals - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text (2S)-2-(3-(1-carboxy-5-(4-211At-astatobenzamido)pentyl) ureido)-pentanedioic acid for PSMA-targeted α-particle radiopharmaceutical therapy
by Kiess, Ana P and Minn, Il and Vaidyanathan, Ganesan and Hobbs, Robert F and Josefsson, Anders and Shen, Colette and Brummet, Mary and Chen, Ying and Choi, Jaeyeon and Koumarianou, Eftychia and Baidoo, Kwamena and Brechbiel, Martin W and Mease, Ronnie C and Sgouros, George and Zalutsky, Michael R and Pomper, Martin G
Journal of Nuclear Medicine, ISSN 0161-5505, 10/2016, Volume 57, Issue 10, pp. 1569 - 1575
Alpha-particle emitters have a high linear energy transfer and short range, offering the potential for treating micrometastases while sparing normal tissues.... 
Astatine | Oncology: GU | Prostate-specific membrane antigen | Radionuclide therapy | Radiation dosimetry | Radiopharmaceuticals | Alpha emitter | Prostate cancer | SURVIVAL | MALIGNANT HUMAN TISSUES | RADIOIMMUNOTHERAPY | RADICAL PROSTATECTOMY | oncology: GU | MEMBRANE ANTIGEN PSMA | alpha emitter | METASTATIC PROSTATE-CANCER | prostate-specific membrane antigen | radiopharmaceuticals | prostate cancer | F-18-DCFBC | radionuclide therapy | astatine | radiation dosimetry | RECURRENCE | INHIBITORS | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiopharmaceuticals - chemistry | Radiopharmaceuticals - pharmacokinetics | Urea - pharmacokinetics | Humans | Organometallic Compounds - pharmacokinetics | Alpha Particles - therapeutic use | Urea - chemistry | Tissue Distribution | Radiopharmaceuticals - metabolism | Kidney - metabolism | Maximum Tolerated Dose | Urea - therapeutic use | Animals | Glutamate Carboxypeptidase II - metabolism | Organometallic Compounds - metabolism | Urea - analogs & derivatives | Radiochemistry | Antigens, Surface - metabolism | Cell Line, Tumor | Organometallic Compounds - therapeutic use | Organometallic Compounds - chemistry | Urea - metabolism | Mice | Radiopharmaceuticals - therapeutic use | Basic Science Investigations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Red‐Emitting Upconverting Nanoparticles for Photodynamic Therapy in Cancer Cells Under Near‐Infrared Excitation
by Tian, Gan and Ren, Wenlu and Yan, Liang and Jian, Shan and Gu, Zhanjun and Zhou, Liangjun and Jin, Shan and Yin, Wenyan and Li, Shoujian and Zhao, Yuliang
Small, ISSN 1613-6810, 06/2013, Volume 9, Issue 11, pp. 1929 - 1938
Upconverting nanoparticles (UCNPs) have attracted considerable attention as potential photosensitizer carriers for photodynamic therapy (PDT) in deep tissues.... 
combinational therapy | fluorescence resonance energy transfer | upconversion | photodynamic therapy | red‐emitting upconverting nanoparticles | red-emitting upconverting nanoparticles | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | DRUG-DELIVERY | STRATEGY | MATERIALS SCIENCE, MULTIDISCIPLINARY | LIGHT | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | FLUORESCENT NANOPARTICLES | CHEMISTRY, MULTIDISCIPLINARY | NM LASER | QUANTUM DOTS | NAYF4 NANOCRYSTALS | DOPANT-CONTROLLED SYNTHESIS | IMAGING AGENT | UP-CONVERSION NANOPARTICLES | Lung Neoplasms - drug therapy | Photosensitizing Agents - chemistry | Porphyrins - therapeutic use | Nanoparticles - chemistry | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Humans | Lung Neoplasms - metabolism | Porphyrins - chemistry | Rats | alpha-Cyclodextrins - chemistry | Singlet Oxygen - metabolism | Animals | Nanoparticles - therapeutic use | Fluorescence Resonance Energy Transfer | Organometallic Compounds - therapeutic use | Indoles - therapeutic use | Organometallic Compounds - chemistry | Mice | Indoles - chemistry | Nanoparticles | Anthracyclines | Chemotherapy | Active oxygen | Phthalocyanins | Cancer cells | Fluorescence | Cyclodextrins | Health aspects | Photochemotherapy | Nanotechnology | Cancer | Oxygen | Photodynamic therapy | Drugs | Nanomaterials | Nanostructure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text MIRD pamphlet No. 22 (Abridged): Radiobiology and dosimetry of α-particle emitters for targeted radionuclide therapy
by Sgouros, George and Roeske, John C and McDevitt, Michael R and Palm, Stig and Allen, Barry J and Fisher, Darrell R and Brill, A. Bertrand and Song, Hong and Howell, Roger W and Akabani, Gamal and Bolch, Wesley E and Meredith, Ruby F and Wessels, Barry W and Zanzonico, Pat B and SNM MIRD Comm and SNM MIRD Committee and Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Journal of Nuclear Medicine, ISSN 0161-5505, 02/2010, Volume 51, Issue 2, pp. 311 - 328
The potential of alpha-particle emitters to treat cancer has been recognized since the early 1900s. Advances in the targeted delivery of radionuclides and... 
Human α-particle emitter dosimetry | Targeted α-particle emitter therapy | α-particle emitters | DIFFERENT IONIZING RADIATIONS | INCORPORATED RADIONUCLIDES | alpha-particle emitters | RELATIVE BIOLOGICAL EFFECTIVENESS | HUMAN-CELLS | ABSORBED FRACTIONS | ACCELERATED HEAVY-IONS | TISSUE-CULTURE | MAMMALIAN-CELLS | RADIOPROTECTORS IN-VIVO | targeted alpha-particle emitter therapy | human alpha-particle emitter dosimetry | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | DOSE-RATE | Radiotherapy Dosage | Cell Death - radiation effects | Radioisotopes - therapeutic use | Humans | Neoplasms, Radiation-Induced - etiology | Radioisotopes - adverse effects | Alpha Particles - adverse effects | Male | Clinical Trials as Topic | Pamphlets | Alpha Particles - therapeutic use | Cell Survival - radiation effects | Radiobiology | Societies, Medical | Radiation-Protective Agents - therapeutic use | Female | Neoplasms - radiotherapy | Relative Biological Effectiveness | Dose-Response Relationship, Radiation | Radiotherapy Planning, Computer-Assisted | targeted α-particle emitter therapy | human α-particle emitter dosimetry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy
by Lee, Dongyoul and Li, Mengshi and Bednarz, Bryan and Schultz, Michael K
Radiation Research, ISSN 0033-7587, 09/2018, Volume 190, Issue 3, pp. 236 - 247
The use of targeted radionuclide therapy for cancer is on the rise. While beta-particle-emitting radionuclides have been extensively explored for targeted... 
SURVIVAL | ELECTRON | NEUROENDOCRINE TUMORS | BETA-EMITTING RADIONUCLIDES | MAMMALIAN-CELLS | S-VALUES | RADIOLABELED SOMATOSTATIN ANALOG | BIOPHYSICS | THYROID-CANCER | BIOLOGY | IN-111 PENTETREOTIDE | RESISTANT PROSTATE-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lead Radioisotopes - therapeutic use | Radioisotopes - therapeutic use | Humans | Alpha Particles - adverse effects | Bismuth - therapeutic use | Alpha Particles - therapeutic use | Neoplasm Metastasis | Beta Particles - adverse effects | Actinium - therapeutic use | Beta Particles - therapeutic use | Neoplasms - radiotherapy | Lutetium - therapeutic use | Neoplasms - pathology | Dose-Response Relationship, Radiation | Yttrium Radioisotopes - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Molecular pathways: Targeted α - Particle radiation therapy
by Baidoo, Kwamena E and Yong, Kwon and Brechbiel, Martin W
Clinical Cancer Research, ISSN 1078-0432, 02/2013, Volume 19, Issue 3, pp. 530 - 537
An alpha-particle, a He-4 nucleus, is exquisitely cytotoxic and indifferent to many limitations associated with conventional chemo-and radiotherapy. The... 
IRRADIATION | PHARMACOKINETICS | ONCOLOGY | IMMUNOTHERAPY | RADIOIMMUNOTHERAPY | DOUBLE-STRAND BREAKS | MYELOID-LEUKEMIA | MECHANISMS | INDUCTION | DOSIMETRY | CELL-DEATH | Neoplasms - metabolism | Neoplasms - radiotherapy | Clinical Trials as Topic | Signal Transduction - radiation effects | Alpha Particles - therapeutic use | Humans | α-Radiation | Cancer therapy | DNA | DNA damage | Hematologic cancer | Clinical trials | Monoclonal antibodies | Radiation therapy | Metastasis | Targeted α-therapy | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Radioimmunotherapy of breast cancer metastases with α-particle emitter 225Ac: Comparing efficacy with 213Bi and 90Y
by Song, Hong and Hobbs, Robert F and Vajravelu, Ravy and Huso, David L and Esaias, Caroline and Apostolidis, Christos and Morgenstern, Alfred and Sgouros, George
Cancer Research, ISSN 0008-5472, 12/2009, Volume 69, Issue 23, pp. 8941 - 8948
alpha-Particles are suitable to treat cancer micrometastases because of their short range and very high linear energy transfer. alpha-Particle emitter... 
Mammary Neoplasms, Experimental - immunology | Lung Neoplasms - metabolism | Lung Neoplasms - radiotherapy | Bismuth - therapeutic use | Alpha Particles - therapeutic use | Mammary Neoplasms, Experimental - metabolism | Bismuth - chemistry | Tissue Distribution | Lung Neoplasms - secondary | Actinium - therapeutic use | Isotope Labeling | Female | Receptor, ErbB-2 - immunology | Yttrium Radioisotopes - therapeutic use | Antibodies, Monoclonal - immunology | Radioisotopes - therapeutic use | Radioimmunotherapy | Rats | Mammary Neoplasms, Experimental - radiotherapy | Mice, Transgenic | Animals | Actinium - chemistry | Immunotoxins - therapeutic use | Immunotoxins - pharmacokinetics | Mice | Radioisotopes - chemistry | Yttrium Radioisotopes - chemistry | Index Medicus | radioimmunotherapy | metastasis | 213Bi | alpha-particle | 225Ac | rat HER-2 | neu
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Green synthesized nanoparticles in the fight against mosquito-borne diseases and cancer—a brief review
by Benelli, Giovanni
Enzyme and Microbial Technology, ISSN 0141-0229, 12/2016, Volume 95, pp. 58 - 68
Nanobiomedicine and parasitology are facing a number of key challenges, which mostly deal with the paucity of effective preventive and curative tools against... 
Plasmodium | Anopheles | Malaria | Mosquito vector control | Chloroquine | Dengue | Artemisinin | Tumor | Zika virus | Culex | Aedes | ANTIPLASMODIAL ACTIVITY | NECROSIS-FACTOR-ALPHA | Tumor Zika virus | SILVER NANOPARTICLES | AEGYPTI DIPTERA-CULICIDAE | IN-VITRO | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PLASMODIUM-FALCIPARUM | VECTOR ANOPHELES-STEPHENSI | DENGUE VIRUS | ZIKA VIRUS | NONTARGET AQUATIC ORGANISMS | Insecticides - pharmacology | Green Chemistry Technology | Plant Extracts - chemistry | Nanoparticles - chemistry | Humans | Nanoparticles - ultrastructure | Culicidae - drug effects | Dengue - prevention & control | Malaria - prevention & control | Culicidae - virology | Neoplasms - therapy | Animals | Insecticides - chemical synthesis | Insect Vectors - drug effects | Nanoparticles - therapeutic use | Culicidae - parasitology | Zika Virus Infection - prevention & control | Insect Control - methods | Nanotechnology | Nanoparticles | Bites and stings | Mosquitoes | Animal behavior | Cancer | Dengue viruses | Cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights